| 000 | 01398 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515211208.0 | ||
| 264 | 0 | _c20100810 | |
| 008 | 201008s 0 0 eng d | ||
| 022 | _a1464-410X | ||
| 024 | 7 |
_a10.1111/j.1464-410X.2010.09272.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYates, David R | |
| 245 | 0 | 0 |
_aFailure of bacille Calmette-Guérin in patients with high risk non-muscle-invasive bladder cancer unsuitable for radical cystectomy: an update of available treatment options. _h[electronic resource] |
| 260 |
_bBJU international _cJul 2010 |
||
| 300 |
_a162-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdjuvants, Immunologic _xtherapeutic use |
| 650 | 0 | 4 | _aAdministration, Intravesical |
| 650 | 0 | 4 |
_aBCG Vaccine _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aCystectomy |
| 650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 |
_aMitomycin _xtherapeutic use |
| 650 | 0 | 4 | _aNeoplasm Invasiveness |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xtherapy |
| 650 | 0 | 4 | _aGemcitabine |
| 700 | 1 | _aRouprêt, Morgan | |
| 773 | 0 |
_tBJU international _gvol. 106 _gno. 2 _gp. 162-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1464-410X.2010.09272.x _zAvailable from publisher's website |
| 999 |
_c19569317 _d19569317 |
||